|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar
|
|
2
|
Siegel R, Ward E, Brawley O and Jemal A:
Cancer statistics, 2011: the impact of eliminating socioeconomic
and racial disparities on premature cancer deaths. CA Cancer J
Clin. 61:212–236. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Yang L, Parkin DM, Ferlay J, Li L and Chen
Y: Estimates of cancer incidence in China for 2000 and projections
for 2005. Cancer Epidemiol Biomarkers Prev. 14:243–250.
2005.PubMed/NCBI
|
|
4
|
Yang L: Incidence and mortality of gastric
cancer in China. World J Gastroenterol. 12:17–20. 2006.
|
|
5
|
Baeuerle PA and Baltimore D: NF-κB: ten
years after. Cell. 87:13–20. 1996.
|
|
6
|
Bours V, Dejardin E, Goujon-Letawe F,
Merville MP and Castronovo V: The NF-kappa B transcription factor
and cancer: high expression of NF-kappa B- and I kappa B-related
proteins in tumor cell lines. Biochem Pharmacol. 47:145–149. 1994.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Baldwin AS: Control of oncogenesis and
cancer therapy resistance by the transcription factor NF-κB. J Clin
Invest. 107:241–246. 2001.
|
|
8
|
Frixen UH, Behrens J, Sachs M, et al:
E-cadherin-mediated cell-cell adhesion prevents invasiveness of
human carcinoma cells. J Cell Biol. 113:173–185. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hirohashi S: Inactivation of the
E-cadherin-mediated cell adhesion system in human cancers. Am J
Pathol. 153:333–339. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Gabbert HE, Mueller W, Schneiders A, et
al: Prognostic value of E-cadherin expression in 413 gastric
carcinomas. Int J Cancer. 69:184–189. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Mao Z, Ma X, Rong Y, et al: Connective
tissue growth factor enhances the migration of gastric cancer
through downregulation of E-cadherin via the NF-κB pathway. Cancer
Sci. 102:104–110. 2011.PubMed/NCBI
|
|
12
|
Ghadimi BM, Behrens J, Hoffmann I, Haensch
W, Birchmeier W and Schlag PM: Immunohistological analysis of
E-cadherin, alpha-, beta-and gamma-catenin expression in colorectal
cancer: implications for cell adhesion and signaling. Eur J Cancer.
35:60–65. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Pignatelli M, Ansari TW, Gunter P, et al:
Loss of membranous E-cadherin expression in pancreatic cancer:
correlation with lymph node metastasis, high grade, and advanced
stage. J Pathol. 174:243–248. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Oka H, Shiozaki H, Kobayashi K, et al:
Expression of E-cadherin cell adhesion molecules in human breast
cancer tissues and its relationship to metastasis. Cancer Res.
53:1696–1701. 1993.PubMed/NCBI
|
|
15
|
Zhou Y, Li G, Wu J, et al:
Clinicopathological significance of E-cadherin, VEGF, and MMPs in
gastric cancer. Tumour Biol. 31:549–558. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kyrlagkitsis I and Karamanolis DG: Genes
and gastric cancer. Hepatogastroenterology. 51:320–327. 2004.
|
|
17
|
Mimata A, Fukamachi H, Eishi Y and Yuasa
Y: Loss of E-cadherin in mouse gastric epithelial cells induces
signet ring-like cells, a possible precursor lesion of diffuse
gastric cancer. Cancer Sci. 102:942–950. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Nieto MA: The snail superfamily of
zinc-finger transcription factors. Nat Rev Mol Cell Biol.
3:155–166. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
19
|
Bonavida B and Baritaki S: Dual role of NO
donors in the reversal of tumor cell resistance and EMT:
downregulation of the NF-κB/Snail/YY1/RKIP circuitry. Nitric Oxide.
24:1–7. 2011.PubMed/NCBI
|
|
20
|
Wu Y and Zhou BP: Snail: more than EMT.
Cell Adh Migr. 4:199–203. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Rosivatz E, Becker I, Specht K, et al:
Differential expression of the epithelial-mesenchymal transition
regulators Snail, SIP1, and Twist in gastric cancer. Am J Pathol.
161:1881–1891. 2002. View Article : Google Scholar
|
|
22
|
Castro Alves C, Rosivatz E, Schott C, et
al: Slug is overexpressed in gastric carcinomas and may act
synergistically with SIP1 and Snail in the down-regulation of
E-cadherin. J Pathol. 211:507–515. 2007.PubMed/NCBI
|
|
23
|
Bosman FT: WHO classification of tumours
of the digestive system. World Health Organization. International
Agency for Research on Cancer; 4th edition. IARC Press; Lyon:
2010
|
|
24
|
Volm M, Koomagi R and Mattern J:
Prognostic value of vascular endothelial growth factor and its
receptor Flt-1 in squamous cell lung cancer. Int J Cancer.
74:64–68. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Vichai V and Kirtikara K: Sulforhodamine B
colorimetric assay for cytotoxicity screening. Nat Protoc.
1:1112–1116. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Woolston C and Martin S: Analysis of tumor
and endothelial cell viability and survival using sulforhodamine B
and clonogenic assays. Methods Mol Biol. 740:45–56. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhou Y, Ran J, Tang C, et al: Effect of
celecoxib on E-cadherin, VEGF, microvessel density and apoptosis in
gastric cancer. Cancer Biol Ther. 6:269–275. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Dentice M, Luongo C, Ambrosio R, et al:
Beta-catenin regulates deiodinase levels and thyroid hormone
signaling in colon cancer cells. Gastroenterology. 143:1037–1047.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Solanas G, Porta-de-la-Riva M, Agustí C,
et al: E-cadherin controls beta-catenin and NF-kappaB
transcriptional activity in mesenchymal gene expression. J Cell
Sci. 121:2224–2234. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Sebastian K, Reza F, Christoph C, et al:
Time dependency and topography of hepatic NF-κB activation after
hemorrhagic shock and resuscitation in mice. Shock. 38:486–492.
2012.PubMed/NCBI
|
|
31
|
Bernardi FC, Felisberto F, Vuolo F, et al:
Oxidative damage, inflammation, and toll-like receptor 4 pathway
are increased in preeclamptic patients: a case-control study. Oxid
Med Cell Longev. 2012:6364192012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Jiang Z, Wu W and Qian ML: Cellular damage
and apoptosis along with changes in NF-kappa B expression were
induced with contrast agent enhanced ultrasound in gastric cancer
cells and hepatoma cells. Cancer Cell Int. 12:82012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Lee KH and Kim JR: Regulation of
HGF-mediated cell proliferation and invasion through NF-κB, JunB,
and MMP-9 cascades in stomach cancer cells. Clin Exp Metastasis.
29:263–272. 2012.PubMed/NCBI
|
|
34
|
Li J, Shen L, Lu FR, et al: Plumbagin
inhibits cell growth and potentiates apoptosis in human gastric
cancer cells in vitro through the NF-κB signaling pathway. Acta
Pharmacol Sin. 33:242–249. 2012.PubMed/NCBI
|
|
35
|
Uchikado Y, Okumura H, Ishigami S, et al:
Increased Slug and decreased E-cadherin expression is related to
poor prognosis in patients with gastric cancer. Gastric Cancer.
14:41–49. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Maehata Y, Hirahashi M, Aishima S, et al:
Significance of dysadherin and E-cadherin expression in
differentiated-type gastric carcinoma with submucosal invasion. Hum
Pathol. 42:558–567. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Biswas DK, Shi Q, Baily S, et al: NF-kappa
B activation in human breast cancer specimens and its role in cell
proliferation and apoptosis. Proc Natl Acad Sci USA.
101:10137–10142. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Dolcet X, Llobet D, Pallares J and
Matias-Guiu X: NF-κB in development and progression of human
cancer. Virchows Arch. 446:475–482. 2005.
|
|
39
|
Han SS, Yun H, Son DJ, et al:
NF-kappaB/STAT3/PI3K signaling crosstalk in iMyc E mu B lymphoma.
Mol Cancer. 9:972010. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Fang Y, Sun H, Zhai J, et al: Antitumor
activity of NF-κB decoy oligodeoxynucleotides in a prostate cancer
cell line. Asian Pac J Cancer Prev. 12:2721–2726. 2011.
|
|
41
|
Dhasarathy A, Kajita M and Wade PA: The
transcription factor snail mediates epithelial to mesenchymal
transitions by repression of estrogen receptor-alpha. Mol
Endocrinol. 21:2907–2918. 2007. View Article : Google Scholar
|
|
42
|
Harder JL, Whiteman EL, Pieczynski JN, Liu
CJ and Margolis B: Snail destabilizes cell surface Crumbs3a.
Traffic. 13:1170–1185. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Becker KF, Rosivatz E, Blechschmidt K,
Kremmer E, Sarbia M and Höfler H: Analysis of the E-cadherin
repressor Snail in primary human cancers. Cells Tissues Organs.
185:204–212. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Blechschmidt K, Kremmer E, Hollweck R, et
al: The E-cadherin repressor snail plays a role in tumor
progression of endometrioid adenocarcinomas. Diagn Mol Pathol.
16:222–228. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Spaderna S, Schmalhofer O, Wahlbuhl M, et
al: The transcriptional repressor ZEB1 promotes metastasis and loss
of cell polarity in cancer. Cancer Res. 68:537–544. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
He H, Chen W, Wang X, et al: Snail is an
independent prognostic predictor for progression and patient
survival of gastric cancer. Cancer Sci. 103:1296–1303. View Article : Google Scholar
|
|
47
|
Bachelder RE, Yoon SO, Franci C, de
Herreros AG and Mercurio AM: Glycogen synthase kinase-3 is an
endogenous inhibitor of Snail transcription: implications for the
epithelial-mesenchymal transition. J Cell Biol. 168:29–33. 2005.
View Article : Google Scholar
|
|
48
|
Julien S, Puig I, Caretti E, et al:
Activation of NF-kappaB by Akt upregulates Snail expression and
induces epithelium mesenchyme transition. Oncogene. 26:7445–7456.
2007. View Article : Google Scholar : PubMed/NCBI
|
